Darren Sherman

Darren Sherman, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Orchestra BioMed Holdings, Inc. and Motus GI Holdings, Inc. The record holds 40 filings, for trades running from 16 February 2018 to 1 October 2026.

On the open market, the record shows 6 purchases worth €203k and 7 sales worth €313k. The net balance comes to €110k on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 21 share grants and 1 option exercise. So far in 2026, the count stands at 1 purchase and 2 sales.

Half of the purchases are above €7,948 and half below. Clusters matter here: 3 out of 4 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 100% of cases; the median change was +53.6%. Past outcomes like these are no guarantee of what comes next.

The latest filing, published on 2 October 2026, reports an open-market sale of €84k in Orchestra BioMed Holdings, Inc. The last insider purchase was made public on 28 August 2026, 57 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.